RJA
IMUC

Raymond James & Associates’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Raymond James & Associates’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-380
Closed -$3K – 3215
2016
Q2 		$3K Sell
380
-8
-2% -$63 ﹤0.01% 2891
2016
Q1 		$4K Buy
+388
New +$4K ﹤0.01% 2815